Tuesday, September 07, 2021 10:38:05 AM
Recent RNXT News
- RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024 • Business Wire • 05/02/2024 01:00:00 PM
- RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement • Business Wire • 04/18/2024 12:30:00 PM
- RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting • Business Wire • 04/16/2024 12:30:00 PM
- RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026 • Business Wire • 04/15/2024 12:00:00 PM
- RenovoRx Announces $11.1 Million at Market Private Placement • Business Wire • 04/08/2024 12:30:00 PM
- RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024 • Business Wire • 04/05/2024 12:30:00 PM
- RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024 • Business Wire • 03/12/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:28:31 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:26:04 PM
- RenovoRx Highlights Key Leadership Promotions • Business Wire • 03/08/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 12:46:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:30:41 PM
- RenovoRx CEO Issues Letter to Shareholders • Business Wire • 02/06/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 12:33:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 11:57:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 11:32:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 11:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 02:06:07 PM
- RenovoRx Closes $6.1 Million Private Placement • Business Wire • 01/29/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 02:50:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 02:50:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 02:50:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 01:30:33 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM